|Grupo de Investigación|
Coordinadora del Área:
Maria José Valverde
Historial del Grupo Investigación
|Cancer and Public Health|
| || |
In Europe, 3.2 million people are diagnosed with cancer every year (mainly colorectal, breast and lung cancer). Despite significant advances in research and treatment, cancer still remains a significant health problem. Cancer is one of the main health problems in the Valencian region and therefore represents one of the main priorities oft the health system, as shown in the Plan de Salud. It is the second most common cause of death, leading to 28.1% of deaths in males and 19.1% in women. It is also the cause of 10% of admissions in public hospitals.
| || |
Lines of Research
1. Research and evaluation of cancer control prevention strategies
This line aims to identify, analyse and evaluate the impact of different policies and interventions, taking place outside the health sector, on cancer. It aims to analyse the risk factors associated with cancer, and develop new intervention methods to promote a cancer-free life for a longer period of time. It also identifies environmental and occupation exposure related to the development of cancer.
2. Research and evaluation of cancer control strategies: secondary prevention of cancer
This line has two main areas. The first area involves close analysis of prevention strategies and the control of screening side effects, as well as strategies for quality control in screening. The second area aims to contribute to the identification of new effective screening examinations for cancer screening of average or high risk populations.
3. Cancer and Health Services
This line analyses developments in the health services related to screening programmes and other health care provisions for cancer care. It also evaluates the patient quality of life and satisfaction. Systematic checks are carried out to produce oncology guides and to evaluate their impact in the health service. It evaluates the cancer care process. We are currently starting a new line of research into how to better inform the population about screening examinations and alternative treatment, in addition to addressing the uncertainty surrounding this issue.
4. Monitoring cancer. The impact of interventions on cancer
5. Inequalities in health and cancer
| || |